Ambalal Sarabhai Enterprises Share Price

BSE
AMBASARABH •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Ambalal Sarabhai Enterprises
Ambalal Sarabhai Enterprises Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Ambalal Sarabhai Enterprises Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
53.08% Fall from 52W High
-17.1
Dividend yield 1yr %
0

Ambalal Sarabhai Enterprises Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Ambalal Sarabhai Enterprises Quarterly Revenue

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
45.97 Cr
44.7 Cr
40.7 Cr
54.35 Cr
43.11 Cr

Ambalal Sarabhai Enterprises Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
183.95 Cr
182.77 Cr
238.76 Cr
194.22 Cr
157.89 Cr
157.35 Cr

Ambalal Sarabhai Enterprises Quarterly Net Profit/Loss

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
2.08 Cr
1.66 Cr
0.71 Cr
10.1 Cr
1.07 Cr

Ambalal Sarabhai Enterprises Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
8.39 Cr
12.14 Cr
40.8 Cr
20.24 Cr
15.44 Cr
2 Cr

Ambalal Sarabhai Enterprises shareholding Pattern

Promoter
31.4%
Foreign Institutions
0.4%
Domestic Institutions
0.1%
Public
68.2%
Promoter
31.4%
Domestic Institutions
0.1%
Public
68.5%
Promoter
31.4%
Public
68.6%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%

Ambalal Sarabhai Enterprises Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
37.50
10Day EMA
37.90
12Day EMA
37.90
20Day EMA
38.00
26Day EMA
38.20
50Day EMA
40.20
100Day EMA
44.50
200Day EMA
48.10
5Day SMA
37.70
10Day SMA
38.60
20Day SMA
37.90
30Day SMA
37.30
50Day SMA
39.00
100Day SMA
46.70
150Day SMA
50.10
200Day SMA
54.00
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
32906 Rs
42185 Rs
Week Rs
76891 Rs
100001 Rs
Month Rs
87529 Rs
121863 Rs
Resistance & Support
36.73
Pivot
Resistance
First Resistance
37.18
Second Resistance
37.91
Third Resistance
38.36
Support
First Support
36.00
Second support
35.55
Third Support
34.82
Relative Strength Index
41.54
Money Flow Index
43.54
MACD
-0.30
MACD Signal
-0.28
Average True Range
2.11
Average Directional Index
25.62
Rate of Change (21)
4.02
Rate of Change (125)
-29.23

Ambalal Sarabhai Enterprises Latest News

22 APR 2025 | Tuesday

Ambalal Sarabhai Enterprises Ltd - 500009 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

22 APR 2025 | Tuesday

Ambalal Sarabhai Enterprises Ltd - 500009 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

10 APR 2025 | Thursday

Ambalal Sarabhai Enterprises Ltd - 500009 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

View More

Ambalal Sarabhai Enterprises Company background

Founded in: 1977
Managing director: Mohal Kartikeya Sarabhai
Ambalal Sarabhai Enterprises Ltd., incorporated on June 5, 1978, houses a range of companies across multidimensional businesses. Each subsidiary is a distinct entity contributing its unique expertise and capabilities. It is one of the oldest pharmaceutical health care companies in India, and today through its group companies it manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and internationally. ASEs strength is to lead with cutting edge technology by creating strategic technology tieups and collaborative partnerships through our broad national and international networksThe Company produces a range of bulk drugs, pharmaceutical preparations and electronic instruments. It operates in two segments, pharmaceuticals and electronics. Pharmaceuticals segment is engaged in manufacture of drugs and formulations. Electronics segment is engaged in manufacture of electronics instruments and services. In the year 1994, the company entered into a technical collaboration with Biobras, Brazil, to manufacture highly purified insulin injections. During the year 199798, the company formed a joint venture company, namely Sarabhai Piramal Pharmaceuticals Ltd with Piramal Enterprises Ltd for marketing of certain products under trademarks being used by the company. During the year 199899, the company signed agreement with B V Chiron, Netherlands for introducing their anticancer drugs in India.During the year 19992000, the company entered into an MoU for marketing of products of Oncology products of Chiron Corporation, USA. The Product Division essentially comprising of Sarabai Chemicals Products was transferred to the joint venture company, Sarabhai Piramal Pharmaceuticals Ltd. In September 2008, the company acquired the manufacturing and marketing company, namely Suvik Hitek Pvt. Ltd. The Ethical Division relaunched the products of Suvik and Sarabhai Chemicals in market. Also, the company acquired Systronics (India) Pvt Ltd. During the year 200809, the Oncology Division launched two new products viz. Fludagem Xtinib. Also, the company promoted a company viz. Vovanties Laboratories Pvt Ltd, a pharmaceutical specialist with a vision to establish a state of the art manufacturing facility specializing in Novel Effervescent Drug Delivery System. During the year 201011, the Company had transferred and assigned as going concern, the business undertaking of Sarabhai Chemicals Bulk Drug Division to Synbiotics Ltd and Electronics Division comprising of Systronics, Teleradand SERC to Systronics (India) Ltd with effect from October 01, 2010.Sarabhai M Chemicals Ltd, a wholly owned subsidiary company started its Vitamin C coated products manufacturing since August 2019.In June 2023, Asence Pharma Pvt., Ltd. a subsidiary of the Company commenced its new oncology and synthetic API plant at Ranoli, Vadodara.
Read More

Ambalal Sarabhai Enterprises FAQs

Ambalal Sarabhai Enterprises share price in the past 1-year return was -21.42. The Ambalal Sarabhai Enterprises share hit a 1-year low of Rs. 34.11 and a 1-year high of Rs. 77.7.

The market cap of Ambalal Sarabhai Enterprises is Rs. 279.41 Cr. as of 30/4/2025.

The PE ratios of Ambalal Sarabhai Enterprises is 21.96 as of 30/4/2025.

The PB ratios of Ambalal Sarabhai Enterprises is 6.19 as of 30/4/2025

You can easily buy Ambalal Sarabhai Enterprises shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Ambalal Sarabhai Enterprises stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -